Обновление к петицииOpen an investigation into Mylan pharmaceuticals price gouging practices around the EpiPen
YOU ASKED FOR IT' — Congress railed on the maker of EpiPen

Nkozi KnightMilwaukee, WI, Соединенные Штаты
23 сент. 2016 г.
Mylan CEO Heather Bresch congressional hearing on EpiPen has now come and gone. Her indifference about the cost of the EpiPen was clear as she looked to justify her $18 million dollar a year base salary.
No one is asking for it to be free but simply affordable. There is clearly more work that must be done in order to right this wrong against hard working Americans. Stay tuned....